1 Hit in 0.039 sec

Tildrakizumab Efficacy by Metabolic Syndrome Status in Psoriasis: Post Hoc Analysis of 3-Year Data from the Phase 3 Resurface 1 And Resurface 2 Studies

Mark G Lebwohl, Nehal N Mehta, Alice B Gottlieb, Alan M Mendelsohn
2020 SKIN The Journal of Cutaneous Medicine  
not available.
doi:10.25251/skin.4.supp.42 fatcat:4guuwzwnfndc3hvsdlxhjxcndy